Company Filing History:

10 out of 949

Chugai Seiyaku Kabushiki Kaisha

patents

3 out of 52,735

Kabushiki Kaisha Toshiba

patents

2 out of 475

Denki Kagaku Kogyo Kabushiki Kaisha

patents

4. 1 out of 1

Chugai Seikayu Kabushiki Kaisha

patent

5. 1 out of 1,235

Nissan Chemical Industries Limited

patents

where one patent can have more than one assignee

Years Active: 1988-2013

Loading Chart...

16 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8470829 - Imidazolidine derivative and use thereof (2013-06-25),

2. 8088916 - Hyaluronic acid-methotrexate conjugate (2012-01-03),

3. 7879887 - α-amino acid derivatives and medicaments containing the same as an active ingredient (2011-02-01),

4. 7807675 - Hyaluronic acid-methotrexate conjugate (2010-10-05),

5. 7803826 - Imidazolidine derivatives (2010-09-28),

6. 7271188 - Imidazolidine derivatives (2007-09-18),

7. 7001887 - Peptide derivatives (2006-02-21),

8. 5977167 - Benzopyran and benzoxazine derivatives (1999-11-02),

9. 5874446 - Benzopyran derivatives (1999-02-23),

10. 5646310 - N-(2-cyanoethyl)-6-fluoroalkyl-2h-1-benzopyran derivatives (1997-07-08),

11. 5614633 - Benzopyran derivatives (1997-03-25),

12. 5448228 - Paging apparatus equipped with a clock function (1995-09-05),

13. 5285493 - Radio tele-communication device with received message displaying feature (1994-02-08),

14. 5264841 - Paging apparatus equipped with a clock function (1993-11-23),

15. 4791209 - Furobenzisoxazole derivatives (1988-12-13),

Title: Haruhiko Sato: A Pioneer in Chemical Innovations

Introduction

Haruhiko Sato, an accomplished inventor based in Gotenba, Japan, holds an impressive portfolio of 16 patents. Known for his expertise in chemical compounds, Sato has significantly contributed to the field of medicinal chemistry, particularly with inventive solutions tailored for therapeutic applications.

Latest Patents

Among his notable innovations are the "Imidazolidine derivative and use thereof" and the "Hyaluronic acid-methotrexate conjugate." The imidazole derivative patent describes a unique chemical structure aimed at enhancing the efficacy of various applications, showcasing Sato's inclination towards practical and innovative solutions. The hyaluronic acid-methotrexate conjugate represents a significant advancement in therapies for joint diseases, wherein methotrexate is effectively linked to hyaluronic acid through a peptide chain, promising enhanced treatment options for patients.

Career Highlights

Throughout his career, Haruhiko Sato has collaborated with prominent companies such as Chugai Pharmaceutical Co., Ltd. and Toshiba Corporation. His work at these institutions has enabled him to harness valuable resources and expertise, further amplifying his contributions to innovative drug development.

Collaborations

Sato has partnered with esteemed colleagues, including Hiroshi Koga and Takenori Ishizawa. Their collective efforts have fostered a collaborative environment that encourages the sharing of insights and advancements in the realm of chemistry and pharmaceuticals.

Conclusion

Haruhiko Sato's pioneering work and substantial patent portfolio underscore his role as a leading innovator in the field of medicinal chemistry. His contributions not only reflect his profound understanding of chemical compounds but also his commitment to addressing complex health issues through innovative solutions. With his continuous work, Sato remains a significant figure in the landscape of chemical inventions.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com